Kerberos Proximal Solutions Announces 200th Rinspiration Case
Mountain View, Calif. – Sep 24, 2004
Kerberos Proximal Solutions Inc. performed its 200th case of Rinspiration this week. Jeffrey Moses, M.D., performed the case at New York Presbyterian/Columbia University Medical Center (NYP/CUMC). Dr. Moses used the Rinspiration System™ in a challenging coronary intervention.
“The Rinspiration System is a good concept, easy to use with some promising features,” said Dr. Moses, professor of Clinical Medicine at Columbia University and director of the Interventional Cardiac Catheterization Laboratory at NYP/CUMC. “Rinspiration” is focal simultaneous rinsing and aspiration administered by a single catheter.
Physician feedback continues to support the use of Rinspiration in the interventional suite. Mark Turco, M.D., performed the first case in the United States with the 6French compatible system at Washington Adventist Hospital earlier this year.
“The Rinspiration Catheter has been a valuable addition to our catheterization laboratory,” Turco said. “Its fast and easy set up, and excellent aspiration of debris has helped treat some of the more complex vessels we see.”
The Rinspiration System will be exhibited at the Transcatheter Cardiovascular Therapeutics (TCT) conference Sept. 27 – Oct. 1, 2004. John Webb, M.D., and Professor Eberhard Grube, respectively, will present clinical data from studies in Canada and Germany at TCT.
“Each case brings a measure of satisfaction to all our employees,” said John MacMahon, president and chief executive officer of Kerberos. “We are focused on supplying physicians with the right tools to Rinspirate in the coronaries and the periphery.”
Kerberos will sponsor a breakfast symposium at TCT Friday, Oct. 1, from 7 a.m. to 8 a.m., moderated by Donald S. Baim, M.D., entitled: “Rinspiration™ for Vascular Lavage: Technology, Techniques and Clinical Results.” All interested physicians are welcome to attend the session, and may register for the symposium and find more information about Kerberos at TCT at the Kerberos Proximal Solutions website: www.kerberos-md.com.
Kerberos Proximal Solutions endeavors to develop products for improved vascular treatment.